In a new study, prolonged use of melatonin as a sleep aid in patients with insomnia was associated with increased risk for ...

The American Heart Association’s (AHA) Scientific Sessions 2025 begin today in New Orleans, Louisiana, and the Cardiology Advisor team is excited to bring to our readers the latest research and ...

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

New research has raised concerns about the long-term use of melatonin supplements, which are widely available for purchase in ...

New research says the popular sleep aid melatonin may negatively impact the heart — but experts caution that more research is ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and at ...

Melatonin is typically considered safe and well-tolerated for short-term use among those who are not pregnant or breastfeeding. That means around 1 to 2 months. There is limited research on the ...

New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant ...

Presentations reveal new insights on heart health, including inflammation, MINOCA, kidney function, and maternal outcomes.

A study links long-term melatonin use to increased heart failure risk and hospitalization. The findings were presented at American Heart Association's Scientific Sessions 2025. Researchers didn't ...

Sacubitril/valsartan significantly reduced cardiomyopathy risk in patients undergoing anthracycline chemotherapy, but further research is needed for broader applicability. Muvalaplin, an oral drug, ...